Lycia Therapeutics prices IPO at $18 per share, raises $317.5 millionOct 23FinancingLycia Therapeutics, Inc
Lycia Therapeutics files for IPO, discloses Phase 1 IgE degrader dataOct 5FinancingLycia Therapeutics, Inc
Sign in